Inside informationEnglish
Press Release: Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- Sanofi
- Filed
- 14/08/2025, 07:00
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 112730_20250814